Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary C Hartman

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Virology|October 10, 2006
Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cellsZachary C Hartman, Esther P Black, Andrea Amalfitano
Virus Research|November 27, 2007
Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applicationsZachary C Hartman, Daniel M Appledorn, Andrea Amalfitano
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2018
Right Time and Place for IL12: Targeted Delivery Stimulates Immune TherapyH Kim Lyerly, Takuya Osada, Zachary C Hartman
Cancer Research|June 19, 2021
Mechanisms of Therapeutic Antitumor Monoclonal AntibodiesLi-Chung Tsao, Jeremy Force, Zachary C Hartman
Cancer Gene Therapy|July 13, 2022
Cancer vaccine strategies using self-replicating RNA viral platformsGabrielle P Dailey, Erika J Crosby, Zachary C Hartman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2023
Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine TargetsErika J Crosby, Zachary C Hartman, H Kim Lyerly
Human Vaccines & Immunotherapeutics|December 13, 2023
CEA vaccinesAnchit Bhagat, Herbert K Lyerly, Michael A Morse, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 11, 2008
The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activityTodd J Cohen, Tomasa Barrientos, Zachary C Hartman, et al.
Cancer Immunology, Immunotherapy : CII|April 3, 2010
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEAElizabeth S Gabitzsch, Younong Xu, Joseph P Balint, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2006
Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement systemAnne Kiang, Zachary C Hartman, Ruth S Everett, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Virology|October 10, 2006
Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cellsZachary C Hartman, Esther P Black, Andrea Amalfitano
Virus Research|November 27, 2007
Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applicationsZachary C Hartman, Daniel M Appledorn, Andrea Amalfitano
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2018
Right Time and Place for IL12: Targeted Delivery Stimulates Immune TherapyH Kim Lyerly, Takuya Osada, Zachary C Hartman
Cancer Research|June 19, 2021
Mechanisms of Therapeutic Antitumor Monoclonal AntibodiesLi-Chung Tsao, Jeremy Force, Zachary C Hartman
Cancer Gene Therapy|July 13, 2022
Cancer vaccine strategies using self-replicating RNA viral platformsGabrielle P Dailey, Erika J Crosby, Zachary C Hartman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2023
Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine TargetsErika J Crosby, Zachary C Hartman, H Kim Lyerly
Human Vaccines & Immunotherapeutics|December 13, 2023
CEA vaccinesAnchit Bhagat, Herbert K Lyerly, Michael A Morse, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 11, 2008
The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activityTodd J Cohen, Tomasa Barrientos, Zachary C Hartman, et al.
Cancer Immunology, Immunotherapy : CII|April 3, 2010
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEAElizabeth S Gabitzsch, Younong Xu, Joseph P Balint, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2006
Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement systemAnne Kiang, Zachary C Hartman, Ruth S Everett, et al.
Pageof 6